Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mesenchymal stem cells (MSCs) are studied for their potential clinical use in regenerative medicine, tissue engineering and tumour therapy. However, the therapeutic application of MSCs in tumour therapy still remains limited unless the immunosuppressive role of MSCs for tumour growth in vivo is better understood. In this study, we investigated the mechanism of MSCs favouring tumour escape from immunologic surveillance in inflammatory microenvironment. We first compared the promotive capacity of bone marrow-derived MSCs on B16 melanoma cells growth in vivo, pre-incubated or not with the inflammatory cytokines interferon (IFN)-γ and tumour necrosis factor (TNF)-α. We showed that the development of B16 melanoma cells is faster when co-injected with MSCs pre-incubated with IFN-γ and TNF-α compared with control groups. Moreover, tumour incidence increases obviously in allogeneic recipients when B16 melanoma cells were co-injected with MSCs pre-incubated with IFN-γ and TNF-α. We then demonstrated that the immunosuppressive function of MSCs was elicited by IFN-γ and TNF-α. These cytokine combinations provoke the expression of inducible nitric oxide synthase (iNOS) by MSCs. The impulsive effect of MSCs treated with inflammatory cytokines on B16 melanoma cells in vivo can be reversed by inhibitor or short interfering RNA of iNOS. Our results suggest that the MSCs in tumour inflammatory microenvironment may be elicited of immunosuppressive function, which will help tumour to escape from the immunity surveillance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.11.014 · Cited by 2,101
Self-citationImmunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166 · cited 1×
“showed that MSCs had displayed side effects related to systemic immunosuppression favouring tumour growth in vivo [18].”
BackgroundHuman mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Research works printed but not linked: 19
- Pittenger, 1999, Multilineage potential of adult human mesenchymal stem cells, Science., 284, 143, 10.1126/science.284.5411.143 · DOI · Paper page
- Barry, 2004, Mesenchymal stem cells: clinical applications and biological characterization, Int J Biochem Cell Biol., 36, 568, 10.1016/j.biocel.2003.11.001 · DOI · Paper page
- da Silva Meirelles, 2006, Mesenchymal stem cells reside in virtually all post-natal organs and tissues, J Cell Sci., 119, 2204, 10.1242/jcs.02932 · DOI · Paper page
- Noel, 2002, Regenerative medicine through mesenchymal stem cells for bone and cartilage repair, Curr Opin Investig Drugs., 3, 1000
- Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood., 109, 228, 10.1182/blood-2006-02-002246 · DOI · Paper page
- Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res., 305, 33, 10.1016/j.yexcr.2004.12.013 · DOI · Paper page
- Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood., 101, 3722, 10.1182/blood-2002-07-2104 · DOI · Paper page
- Koc, 2002, Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH), Bone Marrow Transplant., 30, 215, 10.1038/sj.bmt.1703650 · DOI · Paper page
- Djouad, 2005, Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis, Arthritis Rheum., 52, 1595, 10.1002/art.21012 · DOI · Paper page
- Zappia, 2005, Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, Blood., 106, 1755, 10.1182/blood-2005-04-1496 · DOI · Paper page
- Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood., 103, 4619, 10.1182/blood-2003-11-3909 · DOI · Paper page
- Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood., 105, 1815, 10.1182/blood-2004-04-1559 · DOI · Paper page
- Xu, 2007, Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease, Blood., 109, 4097, 10.1182/blood-2006-09-047332 · DOI · Paper page
- Nauta, 2006, Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting, Blood., 108, 2114, 10.1182/blood-2005-11-011650 · DOI · Paper page
- Sudres, 2006, Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice, J Immunol., 176, 7761, 10.4049/jimmunol.176.12.7761 · DOI · Paper page
- Nakamizo, 2005, Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas, Cancer Res., 65, 3307, 10.1158/0008-5472.CAN-04-1874 · DOI · Paper page
- Niedbala, 2006, Role of nitric oxide in the regulation of T cell functions, Ann Rheum Dis., 65, iii37, 10.1136/ard.2006.058446 · DOI · Paper page
- Xu, 2004, Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro, Exp Biol Med., 229, 623, 10.1177/153537020422900706 · DOI · Paper page
- Hall, 2004, Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells, Cancer Lett., 207, 229, 10.1016/j.canlet.2003.10.033 · DOI
Cited by
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
The roles of mesenchymal stem cells in tumor inflammatory microenvironment
Sun, Z., Wang, S., & Zhao, R. C. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-14 · Cited by 249
“This disrupted iNOS expression reverses the observed tumor-promoting effects of MSCs [79].”
BackgroundMesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
“anti-metastasis [39,40,71, 164,165]”
Galland, S., & Stamenkovic, I. (2020) · The Journal of Pathology · doi:10.1002/path.5357 · Cited by 165
“[28] Bone marrow Human Pancreatic cancer Suppressive Unknown [29] Bone marrow Human Glioma Suppressive Downregulation of PDGF/PDGFR axis [30] Tumor tissue Human Ovarian cancer Promoting Promotion of Akt and XIAP phosphorylation [31] Tumor tissue Human Colon cancer Promoting IL-6/Notch-1/CD44 signaling axis [32] Bone m…”
BackgroundRecent discoveries concerning the tumor - mesenchymal stem cell interactions
Lazennec, G., & Lam, P. Y. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.10.004 · Cited by 117
“Inducible nitric oxide synthase (iNOS) produced by the murine MSCs also exhibit similar T cell suppression effect which led to enhance melanoma cell tumor growth [83].”
Background
Metadata
- Authors
- Han, Z., Tian, Z., Lv, G., Zhang, L., Jiang, G., Sun, K., Wang, C., Bu, X., Li, R., Shi, Y., Wu, M., & Wei, L.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2011-10-24
- Volume
- 15
- Issue
- 11
- Pages
- 2343-2352
- ISSN
- 1582-1838 (ISSN-L)
- OpenAlex
- W2036958183
- Cited by
- 76
- References
- 4
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 1408 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. https://app.cochat.ai/papers/10.1111/j.1582-4934.2010.01215.x
- The paper
- Han, Z., Tian, Z., Lv, G., Zhang, L., Jiang, G., Sun, K., Wang, C., Bu, X., Li, R., Shi, Y., Wu, M., & Wei, L. (2011). Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2010.01215.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.